The Clinical Trials Research Center, part of the Canadian Center for Vaccinology, is always looking for volunteers to participate in clinical trials. In a typical vaccine clinical trial, people of any age (depending on the vaccine) are vaccinated then monitored for months or years to see if the vaccine is effective and safe. The trials are thoroughly regulated by health authorities to ensure participant safety and confidentiality.
The vaccine used in a trial may be in one of the following stages of development:
Phase I - first stage of testing in humans (20-50 people)
Phase II - testing larger groups of people (20-300)
Phase III - randomized, controlled, multicenter trials (300-3,000)
Phase IV - also known as Post Marketing Surveillance, is ongoing surveillance of a vaccine or drug after it has been approved by Health Canada as safe and effective
Phase I - first stage of testing in humans (20-50 people)
Phase II - testing larger groups of people (20-300)
Phase III - randomized, controlled, multicenter trials (300-3,000)
Phase IV - also known as Post Marketing Surveillance, is ongoing surveillance of a vaccine or drug after it has been approved by Health Canada as safe and effective
There are many personal benefits to participating in this research, in addition to your valuable contribution to health research. The benefits and risks will be thoroughly discussed with you before any decisions are made. Contact information for each study is included in the descriptions below. Participation is entirely voluntary and you may withdraw from the trial at any time.
* * * * *
*Flu vaccine for children 1 to 4 years
Did your child receive the H1N1 vaccine last year?
Do you plan on giving your child the regular influenza (flu) vaccine this year?
The IWK Health Centre is doing a research study in August and September for children 1 to 4 years old using the regular flu vaccine.
If you are interested in receiving more information, please call Jill Mutch 470-3860 or email jill.mutch@iwk.nshealth.ca
*Participants will be compensated for their time commitment and parking.
Information and authorization form [pdf]
posted 1 September 2010
*Participants will be compensated for their time commitment and parking.
Information and authorization form [pdf]
posted 1 September 2010
*HPV Vaccine Study for Girls
If you are a girl between 12-15 years of age and have received 3 shots of GARDASIL™, you may be eligible to take part in this study. For more information call Robyn 470-7839 or email Robyn.sani@iwk.nshealth.ca
posted 16 July 2010
*Did you receive the H1N1 vaccine while pregnant?
If you answered “yes”, you may be eligible to participate in this study.
The purpose of this study is to collect data and establish a registry in order to evaluate the pregnancy and baby outcomes of women who received the H1N1 vaccine while pregnant.
For more information please call:
Sarah De Coutere 470-3885
posted 30 April 2010
*Maternal Immunization Study
Immunization of women with Diphtheria and Tetanus Toxoids combined with Acellular Pertussis (Tdap) during the mid third trimester of pregnancy: an evaluation of the potential for immunological protection for the neonate.
Advertisement [pdf]
Information and Authorization Form [pdf]
posted 26 January 2010
*Evaluation of Meningococcal C Conjugate Vaccine Programs in Canadian Children
Looking at the protection levels comparing different dosing schedules of the vaccine in 3 Canadian provinces
Advertisement [pdf]
Information and Authorization Form [pdf]
posted 26 January 26 2010
